CORE ADANIPORTS+0.24% BIRET-0.24% BRIGADE-0.85% DLF-1.17% EMBASSY+1.10% GMRAIRPORT+0.00% GODREJPROP+0.19% IRB+3.46% LODHA-0.98% LT-1.76% MAHLIFE-1.64% MINDSPACE-1.39% NCC-0.64% OBEROIRLTY-0.14% PHOENIXLTD+0.11% PRESTIGE-0.22% SOBHA+0.95% as of 2026-08-26 16:27 UTC

The Annexure

Desk› Healthcare› Samrat Pharmachem Ltd

Samrat Pharmachem Ltd

BSE 530125 SAMRATPH INE103E01016
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Filing rhythm · 60 trading days

8 filings · 1 material · busiest 2026-06-29 and 2026-07-17

What it files

Newspaper Publication2 Trading Window2 Board Outcome1 Compliance Certificate1 Auditor Appointment1 Board Meeting1

Filings

8 in the window

  1. 19 August 2026

    Newspaper Publication

    Newspaper Publication

    Newspaper Publication of extract of Standalone Unaudited Financial Results for the quarter ended June 30, 2026.

    Company Update / Newspaper Publication View filing →

  2. 14 August 2026

    Board Outcome

    Board Meeting Outcome for Outcome Of The Board Meeting Of The Company Held Today

    The Board considered and adopted the unaudited financial results for the quarter ended June 30, 2026

    Board Meeting / Outcome of Board Meeting View filing →

  3. 17 July 2026

    Compliance Certificate

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Certificate under Reg. 74(5) of SEBI (DP) Regulations for the quarter ended 30th June 2026

    Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

  4. 17 July 2026

    Auditor Appointment

    Appointment of Statutory Auditor/s

    Appointment of Statutory Auditors for the company from 34th Annual General Meeting to 39th Annual General Meeting

    Company Update / Appointment of Statutory Auditor/s View filing →

  5. 30 June 2026

    Board Meeting

    Board Meeting Intimation for Notice Of Board Meeting For Un-Audited Financial Results For The Quarter Ended June 30, 2026

    Samrat Pharmachem Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve Approval of Un-Audited Financial ....

    Board Meeting / Board Meeting View filing →

  6. 29 June 2026

    Trading Window

    Closure of Trading Window

    Intimation of Closure of Trading Window for the quarter ended June 30, 2026

    Insider Trading / SAST / Closure of Trading Window View filing →

  7. 29 June 2026

    Trading Window

    Closure of Trading Window

    Intimation of Closure of Trading Window for the quarter ended June 30, 2026

    Insider Trading / SAST / Closure of Trading Window View filing →

  8. 4 June 2026

    Newspaper Publication

    Newspaper Publication

    Newspaper Publication of Extract of the Standalone Audited Financial Results for the year ended March 31, 2026.

    Company Update / Newspaper Publication View filing →